 |
Back to home »
Top Stories
» ICAAC 2007
  
Interview with a Hep C Activist & Survivor
September 18, 2007
Peter Staley interviews Jules Levin, an activist and survivor of hepatitis C and HIV coinfection, about the latest in HCV treatment and prevention.
NEW! Scroll down to comment on this story.
Previous Comments:
comments 1 - 3 (of 3 total)
greg gilley, spencer, 2008-09-16 11:59:00
i have a question not a comment that i hope u can help me with i took a u.a. and it came back poss. for t.h.c. and i havent smoked in over a month can rebetol r pegintron that i take for my hep. c have any thng to do with the levels of t.h.c. in my system ?????
johnny, , 2007-09-20 07:14:05
Been HIV Hep C positive for 23 years, still a stigma, even in NY. told 3 person, they aren't my friends anymore.
johnny, new york, 2007-09-20 07:08:10
Aids is still a stigma out there, once you tell someone you are hiv positive, people turn their back on you, so I don't tell nobody anymore. HIV positive 23 years heb C and looking good.
comments 1 - 3 (of 3 total)
[Go to top]
|
|
|
Peter Staley asks Dr. Sharon Walmsley what women need to know about HIV and antivirals, and gender differences needing more research.
Peter Staley asks Dr. Joe Eron about the latest data on soon-to-be-approved Isentress and an entry inhibitor you might inject just once every other week.
Peter Staley asks Dr. Joe Eron about the good news on a challenging drug -- newly-approved Selzentry -- and the very potent new protease inhibitor, Prezista.
Peter Staley talks with Matt Sharp about his activism, his new regimen, and his facial lipo fix.
Peter Staley interviews Jules Levin, an activist and survivor of hepatitis C and HIV coinfection, about the latest in HCV treatment and prevention.